Handling Editor : Alejandro Forner Gonzlez Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study
Availability is not guaranteed and may change based on pharmacy supply and regulatory conditions
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
This dual action significantly enhances insulin secretion, lowers glucagon levels, and slows gastric emptying, contributing to improved glycemic control and effective fat reduction
Who these treatments are for GLP-1 medications are approved for adults with:Type 2 diabetesObesity (BMI of 30 kg/m or higher) A BMI of 27 kg/m or higher with at least one weight-related condition such as high blood pressure Among individuals with a BMI of 27 kg/m or more, additional benefits have been found
The preparatory steps for the test might require you to fast or stop taking certain medications